APOBEC3F determinants of HIV-1 Vif sensitivity

Journal of Virology

Volumn 88, Issue 21, 2014, Pages 12923-12927

  Land, Allison M ^a   Shaban, Nadine M ^a   Evans, Leah ^a   Hultquist, Judd F ^a,b   Albin, John S ^a,c   Harris, Reuben S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; GREEN FLUORESCENT PROTEIN; MUTANT PROTEIN; VIF PROTEIN; APOBEC3F PROTEIN, HUMAN; CYTOSINE DEAMINASE; RECOMBINANT PROTEIN; VIF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ALPHA HELIX; AMINO ACID SUBSTITUTION; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CD4 LYMPHOCYTE COUNT; CLONE; COMPLEX FORMATION; CRYSTAL STRUCTURE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN MOTIF; SPECIES DIFFERENTIATION; STRUCTURE ANALYSIS; VIRUS CELL INTERACTION; VIRUS REPLICATION; ANIMAL; GENETICS; IMMUNOLOGY; METABOLISM; PROTEIN ANALYSIS; RHESUS MONKEY;

AMINO ACID SUBSTITUTION; ANIMALS; CYTOSINE DEAMINASE; DNA MUTATIONAL ANALYSIS; HIV-1; HUMANS; MACACA MULATTA; MUTANT PROTEINS; PROTEIN INTERACTION MAPPING; RECOMBINANT PROTEINS; VIF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84907992902     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02362-14     Document Type: Article

References (20)

1. Refsland EW, Harris RS. 2013. The APOBEC3 family of retroelement restriction factors. Curr. Top. Microbiol. Immunol. 371:1-27. http://dx.doi.org/10.1007/978-3-642-37765-5_1.
2. Desimmie BA, Delviks-Frankenberrry KA, Burdick RC, Qi D, Izumi T, Pathak VK. 2014. Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all. J. Mol. Biol. 426:1220-1245. http://dx.doi.org/10.1016/j.jmb.2013.10.033.
3. Land AM, Ball TB, Luo M, Pilon R, Sandstrom P, Embree JE, Wachihi C, Kimani J, Plummer FA. 2008. Human immunodeficiency virus (HIV) type 1 proviral hypermutation correlates with CD4 count in HIV-infected women from Kenya. J. Virol. 82:8172-8182. http://dx.doi.org/10.1128 /JVI.01115-08.
4. Fitzgibbon JE, Mazar S, Dubin DT. 1993. A new type of G->A hypermutation affecting human immunodeficiency virus. AIDS Res. Hum. Retroviruses 9:833-838. http://dx.doi.org/10.1089/aid.1993.9.833.
5. Janini M, Rogers M, Birx DR, McCutchan FE. 2001. Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells. J. Virol. 75:7973-7986. http://dx.doi.org/10.1128/JVI.75.17.7973-7986.2001.
6. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, Watt IN, Neuberger MS, Malim MH. 2003. DNA deamination mediates innate immunity to retroviral infection. Cell 113:803-809. http://dx.doi.org/10.1016/S0092-8674(03)00423-9.
7. Yu Q, Konig R, Pillai S, Chiles K, Kearney M, Palmer S, Richman D, Coffin JM, Landau NR. 2004. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat. Struct. Mol. Biol. 11:435-442. http://dx.doi.org/10.1038/nsmb758.
8. Harris RS, Hultquist JF, Evans DT. 2012. The restriction factors of human immunodeficiency virus. J. Biol. Chem. 287:40875-40883. http: //dx.doi.org/10.1074/jbc.R112.416925.
9. Bohn MF, Shandilya SM, Albin JS, Kouno T, Anderson BD, McDougle RM, Carpenter MA, Rathore A, Evans L, Davis AN, Zhang J, Lu Y, Somasundaran M, Matsuo H, Harris RS, Schiffer CA. 2013. Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain. Structure 21:1042-1050. http://dx.doi.org/10.1016/j.str.2013.04.010.
10. Siu KK, Sultana A, Azimi FC, Lee JE. 2013. Structural determinants of HIV-1 Vif susceptibility andDNAbinding in APOBEC3F. Nat. Commun. 4:2593. http://dx.doi.org/10.1038/ncomms3593.
11. Albin JS, LaRue RS, Weaver JA, Brown WL, Shindo K, Harjes E, Matsuo H, Harris RS. 2010. A single amino acid in human APOBEC3F alters susceptibility to HIV-1 Vif. J. Biol. Chem. 285:40785-40792. http: //dx.doi.org/10.1074/jbc.M110.173161.
12. Smith JL, Pathak VK. 2010. Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif. J. Virol. 84:12599-12608 http://dx.doi.org/10.1128/JVI.01437-10.
13. Kitamura S, Ode H, Nakashima M, Imahashi M, Naganawa Y, Kurosawa T, Yokomaku Y, Yamane T, Watanabe N, Suzuki A, Sugiura W, Iwatani Y. 2012. The APOBEC3C crystal structure and the interface for HIV-1 Vif binding. Nat. Struct. Mol. Biol. 19:1005-1010. http://dx.doi.org /10.1038/nsmb.2378.
14. Virgen CA, Hatziioannou T. 2007. Antiretroviral activity and Vif sensitivity of rhesus macaque APOBEC3 proteins. J. Virol. 81:13932-13937. http://dx.doi.org/10.1128/JVI.01760-07.
15. Zennou V, Bieniasz PD. 2006. Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates. Virology 349:31-40 http://dx.doi.org/10.1016/j.virol.2005.12.035.
16. Haché G, Shindo K, Albin JS, Harris RS. 2008. Evolution of HIV-1 isolates that use a novel Vif-independent mechanism to resist restriction by human APOBEC3G. Curr. Biol. 18:819-824. http://dx.doi.org/10.1016/j.cub.2008.04.073.
17. Hultquist JF, Lengyel JA, Refsland EW, LaRue RS, Lackey L, Brown WL, Harris RS. 2011. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1. J. Virol. 85:11220-11234. http://dx.doi.org/10.1128/JVI.05238-11.
18. Refsland EW, Stenglein MD, Shindo K, Albin JS, Brown WL, Harris RS. 2010 Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res. 38:4274-4284. http://dx.doi.org/10.1093/nar/gkq174.
19. Albin JS, Haché G, Hultquist JF, Brown WL, Harris RS. 2010. Longterm restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function. J. Virol. 84:10209-10219. http: //dx.doi.org/10.1128/JVI.00632-10.
20. Guo Y, Dong L, Qiu X, Wang Y, Zhang B, Liu H, Yu Y, Zang Y, Yang M, Huang Z. 2014. Structural basis for hijacking CBF-beta and CUL5 E3 ligase complex by HIV-1 Vif. Nature 505:229-233. http://dx.doi.org/10.1038/nature12884.